Jazz Pharmaceuticals plc — Director's Dealing 2011

Feb 16, 2011

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: JAZZ PHARMACEUTICALS INC (JAZZ)
CIK: 0001232524
Period of Report: 2011-02-08

Reporting Person: Cox Russell J. (SVP, Sales and Marketing)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option (right to buy)	$8.23	2020-08-24	Common Stock (60000)		Direct

Footnotes

F1: This option vests over four years measured from the vesting commencement date, July 21, 2010, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter.